Target intelligence / Profile preview

Peroxiredoxin 2 pseudogene 3 (PRDX2P3)

Target
PRDX2P3
Molecular classification
Other (Pseudogene)
01

Overview

Peroxiredoxin 2 pseudogene 3 (PRDX2P3) is classified as a pseudogene, which means it is a non-functional segment of DNA that arises from a previously functional gene but has accumulated mutations—such as frameshifts or premature stop codons—rendering it incapable of encoding a functional protein[4][6]. PRDX2P3 is related to the peroxiredoxin family, specifically peroxiredoxin 2 (PRDX2), which encodes an antioxidant enzyme that reduces hydrogen peroxide and alkyl hydroperoxides in cells[1]. However, PRDX2P3, as a pseudogene, does not produce any protein product and has no known biological activity or role in human disease. PRDX2P3 is a non-functional pseudogene derived from the peroxiredoxin 2 gene. It does not encode a functional protein or participate in any known biological pathway or disease process, nor does it interact with therapeutic agents. It should not be considered a therapeutic target, and its appearance in a drug target list is likely due to database noise or misannotation[4][6].

Other names
PRDX2P3

Beyond the preview

Go deeper on Peroxiredoxin 2 pseudogene 3 (PRDX2P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peroxiredoxin 2 pseudogene 3 (PRDX2P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call